DMAA CIK: 2028614

Drugs Made In America Acquisition Corp.

  • United States
  • Financials
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
0.00
FY25:
0.01
(positive)
Change from FY24 to FY25
millions USD
FY24:
0.55
FY25:
240
Total assets
Change from FY24 to FY25
millions USD
FY24:
0.55
FY25:
240

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
0.80
FY25:
0.38
(negative)
millions USD
FY24:
0
FY25:
6.90
(positive)
Change from FY24 to FY25
millions USD
FY24:
−0.24
FY25:
−7.26
Total liabilities & equity
millions USD
FY24:
0.55
FY25:
–

All amounts in millions USD Data source:SEC EDGAR